For an Executive Summary of this report please contact ediz.ibrahim@visiongain.com (+44 (0)20 7549 9976) or refer to our website http://www.visiongain.com/Report/1198/Advanced-Wound-Care-World-Market-Forecast-2014-2024

1. Advanced Wound Care: World Market
Forecast 2014-2024 & Future Prospects
for Leading Companies
©notice
This material is copyright by visiongain. It is against the law to reproduce any of this material without the prior written agreement of visiongain. You cannot photocopy, fax, download to database or duplicate in any other way any of the material contained in this report. Each purchase and single copy is for personal use only.

2. Contents
1. Executive Summary
1.1 Market Highlights
1.2 Overview of the Report Content
1.3 Research and Analysis Methods
1.4 Glossary of Terms Related to Advanced Wound Care
2. An Introduction to Wounds and Wound Care
2.1 Wound: A Concise Definition
2.2 Wounds: Healing-Based Classification
2.2.1 Acute Wounds
2.2.2 Chronic Wounds
2.2.2.1 The Rising Prevalence of Chronic Wounds
2.2.3 Burns
2.3 An introduction to the Skin
2.4 The Phases of Wound Healing
2.4.1 The inflammatory Phase of Wound Healing
2.4.2 The Proliferation Phase of Wound Healing
2.4.3 The Fibroblastic Phase of Wound Healing
2.4.4 The Maturation Phase of Wound Healing
2.5 Wound Care
2.5.1 The Role of Wound Dressing
2.5.2 Wound Care: A Journey through History
2.6 Classification of Wound Care Therapies
2.6.1 Traditional Wound Care
2.6.1.1 Composite Dressings
2.6.1.2 Absorptive Dressings
2.6.1.3 Gauze Dressings
2.6.1.4 Contact Layers
www.visiongain.com

3. Contents
2.6.1.5 Compression Therapy
2.6.2 Advanced Wound Care
2.6.2.1 Moist Wound Care
2.6.2.1.1 Hydrocolloid Dressings
2.6.2.1.2 Foam Dressings
2.6.2.1.3 Alginate Dressings
2.6.2.1.4 Hydrogel Dressings
2.6.2.2 Wound Care Devices
2.6.2.2.1 Ultrasound for Wound Therapy
2.6.2.2.2 Negative Pressure Wound Therapy (NPWT)
2.6.2.3 Wound Care Biologics
2.6.2.3.1 Cell Based Therapies
2.6.2.3.2 Skin Replacement Therapies
2.6.2.3.3 Collagen Based Therapies
2.7 Regulation of Medical Devices
2.7.1 The US Approval and Regulation System
2.7.2 The EU Approval and Regulation System
2.7.2.1 Post-marketing Surveillance in the EU
3. The Global Advanced Wound Care Market 2014-2024
3.1 The Global Medical Device Market in 2012 and 2013
3.2 Wound Care: Global Market Overview, 2012 and 2013
3.2.1 Global Wound Care Market Trends
3.3 The Advanced Wound Care Market in 2012 and 2013
3.3.1 Advanced Wound Care: Market Forecast 2014-2024
3.4 Changing Market Shares by Sector, 2014-2024
www.visiongain.com

4. Contents
4. Moist Wound Care Market 2014-2024
4.1 Moist Wound Care: Global Market Overview, 2012 and 2013
4.1.1 Moist Wound Care: Market Forecast 2014-2024
4.2 Moist Wound Care Market Breakdown
4.2.1 Hydrocolloid Dressings: Analysis and Forecast, 2014-2024
4.2.2 Foam Dressings: Analysis and Forecast, 2014-2024
4.2.3 Alginate Dressings: Analysis and Forecast, 2014-2024
4.2.4 Hydrogel Dressings: Analysis and Forecast, 2014-2024
4.2.5 Other Moist Wound Care Products: Analysis and Forecast, 2014-2024
4.3 Moist Wound Care: Pipeline Products, 2014
4.3.1 NanoDOX: A Topical Gel
4.3.2. ‘1’ Primary Wound Dressing: A Cell-Proliferating Spray
4.4 SWOT Analysis of the Moist Wound Care Market, 2014-2024
4.4.1 Strengths
4.4.1.1 Greater Effectiveness Compared with Traditional Wound Care
4.4.1.2 Large Range of Available Products
4.4.2 Weaknesses
4.4.2.1 A Diminishing R&D Pipeline
4.4.2.2 Questionable Effectiveness in Comparison to Some Devices and Biologics
4.4.3 Opportunities
4.4.3.1 More Affordable Compared to Wound Care Devices and Biologics
4.4.3.2 Increasing Prevalence of Chronic Wounds
4.4.4 Threats
4.4.4.1 The Threat of Emerging Technologies
4.4.4.2 Decreasing R&D Funding will Impact on Innovation
5. Wound Care Devices Market 2014-2024
5.1 Wound Care Devices: Global Market Overview, 2012 and 2013
www.visiongain.com

5. Contents
5.1.1 Wound Care Devices Market Forecast 2014-2024
5.2 Wound Care Devices Market Breakdown
5.2.1 NPWT: Largest Segment of the Wound Care Devices Market
5.2.1.1 NPWT Market: Leading Products
5.2.1.2 V.A.C. Therapy
5.2.1.3 RENASYS Systems
5.2.1.4 Other NPWT Systems
5.2.1.5 NPWT Market: Analysis and Forecast, 2014-2024
5.2.2 Ultrasound Wound Therapy
5.2.2.1 Ultrasound Wound Therapy: Leading Products
5.2.2.2 Ultrasound Wound Therapy Market: Analysis and Forecast, 2014-2024
5.2.3 Other Wound Care Devices
5.2.3.1 Electrical Stimulation
5.3 Wound Care Devices: Pipeline Products, 2014
5.3.1 dermaPACE, Sanuwave Health
5.3.2 O-ACE-Sys, Ingenious Technologies Corporation
5.3.3 Red Light Wave Therapy, Lightwave Technologies
5.4 SWOT Analysis of the Wound Care Devices Market, 2014-2024
5.4.1 Strengths
5.4.1.1 Continuous Innovation and a Strong R&D pipeline
5.4.1.2 Higher Effectiveness Compared with Other Treatments
5.4.2 Weaknesses
5.4.2.1 The Dominance of Negative Pressure Wound Therapy
5.4.2.2 An Oligopolistic Market
5.4.3 Opportunities
5.4.3.1 Decreasing Prices will Drive Market Growth
5.4.3.2 Increasing Prevalence of Chronic Wounds
5.4.4 Threats
5.4.4.1 Litigation: A Threat to Innovation
www.visiongain.com

6. Contents
6. Wound Care Biologics Market 2014-2024
6.1 Wound Care Biologics: Global Market Overview, 2012 and 2013
6.1.1 Wound Care Biologics Market Forecast 2014-2024
6.2 Wound Care Biologics Market Breakdown
6.2.1 Skin Replacement Therapies: High Growth Potential
6.2.1.1 Skin Replacement Therapies Market: Leading Products
6.2.1.1.1 Apligraf, Organogenesis
6.2.1.1.2 Dermagraft, Organogenesis (Formerly of Shire Regenerative
Medicine)
6.2.1.1.3 Other Skin Replacement Therapies
6.2.1.2 Skin Replacement Therapies Market: Pipeline Products, 2014
6.2.1.3 Skin Replacement Therapies: Analysis and Forecast, 2014-2024
6.2.2 Collagen Based Therapies
6.2.2.1 Collagen Based Therapies: Leading Products
6.2.2.2 Collagen Based Therapies: Analysis and Forecast, 2014-2024
6.2.3 Cell Therapies
6.2.3.1 Cell Therapies Market: Leading Products
6.2.3.2 Cell Therapies: Analysis and Forecast, 2014-2024
6.2.4 Other Wound Care Biologics
6.3 Wound Care Biologics: Pipeline Products, 2014
6.3.1 Stem Cells
6.3.1.1 Stem Cell Skin Gun, Mc Gowan Institute for Regenerative Medicine:
University of Pittsburgh
6.3.1.2 Mesenchymal Stem Cells: Nara University, Japan
6.3.2 Nanotechnology
6.3.2.1 Phytochemical Tissue Bonding: Harvard University Institute of
Photomedicine
6.3.2.2 DermaFuse: Missouri S&T and Mo-Sci Corporation
6.3.3 Artificial Skin
www.visiongain.com

7. Contents
6.3.3.1 ReCell: Avita Medical
6.3.3.2 e-Skin: UC Berkeley
6.3.3.3 Automated Artificial Skin Production: Fraunhofer Institute
6.3.4 Collagen Based Wound Therapy: Cornell University
6.4 SWOT Analysis of the Wound Care Biologics Market, 2014-2024
6.4.1 Strengths
6.4.1.1 Fresh Innovations Producing New Technologies
6.4.1.2 Greater Effectiveness of Biologics
6.4.1.3 Rich R&D Pipeline: A Driver for Market Growth
6.4.2 Weaknesses
6.4.2.1 Barriers to Entry: High
6.4.2.2 The Dominance of Small Biotech Companies
6.4.2.3 The Price of Biologics: A Potential Restraint to Reimbursement
6.4.3 Opportunities
6.4.3.1 The Prospect of Diagnostic Testing
6.4.3.2 Rising Prevalence of Chronic Wounds
6.4.3.3 Stem Cells: Possibility for the Treatment of Multiple Indications
6.4.4 Threats
6.4.4.1 The Competition from Moist Wound Care and Devices
6.4.4.2 High Barrier to Entry: A Strong Deterrent
7. Leading National Advanced Wound Care Markets 2014-2024
7.1 The Advanced Wound Care Market by Regional Sales
7.1.1 The Global Distribution of Advanced Wound Care in 2012 and 2013
7.2 Leading National Markets: Forecast, 2014-2024
7.2.1 Changing Market Shares by Region, 2014-2024
7.3 Regional Advanced Wound Care Markets: Analysis and Forecasts, 2014-2024
7.3.1 United States: A Tale of Taxes and Changing Reimbursement Models
7.3.2 The EU5 Markets: Europe’s Leading AWC Markets
www.visiongain.com

8. Contents
7.3.2.1 EU5: Changing Market Shares by Country, 2014-2024
7.3.2.2 Germany: Europe’s Largest Advanced Wound Care Market
7.3.2.3 France: Cumbersome Approval Process Slowing Growth
7.3.2.4 UK: Hospital Inpatients Raising Wound Care Needs
7.3.2.5 Spain: Rationalisation of Healthcare Expenditure Impacting Sales
7.3.2.6 Italy: Gloom Outlook Compounded by Dropping Credit Ratings
7.3.3 Japan: An Aging Population Putting a Strain on Healthcare Budgets
7.3.4 The BRIC Nations
7.3.4.1 China: High Unmet Needs and Expanding Healthcare Coverage will Drive
Growth
7.3.4.2 India: High Domestic Growth and a Rapidly Expanding Economy
7.3.4.3 Russia: Irregularities in Legislations Hindering Growth
7.3.4.4 Brazil: Expanding Waistlines and Diabetic Population
7.3.5 South Korea: A Highly Attractive Market to Multinationals
8. Leading Companies in the Advanced Wound Care Market 2014
8.1 Kinetic Concept Inc: Global Market Leader
8.1.1 NPWT: A Major Market for KCI
8.1.2 VAC Therapy (NPWT): A Success Story
8.1.3 Systagenix and Kinetic Concept Merger
8.2 Smith & Nephew
8.2.1 S&N’s Advanced Wound Management
8.3 Molnlycke Healthcare
8.3.1 Molnlycke’s Advanced Wound Care Product Range
8.3.2 Molnlycke: Revenue Analysis, 2012 and 2013
8.4 ConvaTec
8.4.1 ConvaTec Revenue Analysis, 2012 and 2013
8.4.2 Wound Therapeutics: A Golden Goose for ConvaTec
8.5 3M
www.visiongain.com

9. Contents
8.5.1 3M: Skin & Wound Care
8.5.2 3M Healthcare Revenue Analysis, 2012 and 2013
8.6 Coloplast
8.6.1 Coloplast’s European Orientation
9. Expert Opinions
9.1 Interview with Mr. Nissim Mashiach, President and Chief Executive Officer, MacroCure
9.1.1 On the Current State of the Advanced Wound Care Market
9.1.2 On the Fate of the Moist Wound Care Sector
9.1.3 MacroCure’s Place in the Advanced Wound Care Market
9.1.4 On the Company’s Growth Strategy and European Expansion
9.1.5 The Multi-Faceted Nature of Wound Care and Wound Healing
9.1.6 On the Challenges Facing the Advanced Wound Care Market
9.1.7 Possible Use of Advanced Wound Care Therapies for Other Indications
9.1.8 Views on the Future Prospects of the Market
10. Conclusions
10.1 Market Overview
10.2 Wound Care Devices and Biologics Set for Rapid Sales Boost
10.3 Rising Prevalence of Chronic Wounds: A Driver for Growth
10.4 Emerging Markets will help in Driving Growth
10.5 Moist Wound Care: Market Summary
10.6 Wound Care Devices: Market Summary
10.7 Wound Care Biologics: Market Summary
www.visiongain.com

10. Contents
List of Tables
Table 2.1 Burn Assessment: The ‘Rule of Nine’ Total Body Classification System (%)
Table 2.2 The Classification of Burns by Depth: Degree Classification System
Table 2.3 The Classification of Burns by Severity
Table 2.4 Advanced Wound Care: Sectors and Descriptions, 2014
Table 2.5 Advantages and Disadvantages of Moist Wound Care
Table 2.6 Advantages and Disadvantages of Skin Replacement Therapy
Table 2.7 Skin Graft Types and their Descriptions
Table 3.1 The Medical Devices Market: Revenues ($bn) and Market Shares (%) by Sector, 2012
Table 3.2 Global Wound Care Market: Revenue ($bn) and Market Share (%) by Sector, 2012
Table 3.3 The Advanced Wound Care Market: Revenues ($bn), Market Shares (%) and Growth
(%) by Sector, 2012 and 2013
Table 3.4 The Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%) by
Sector, 2012-2024
Table 3.5 Advanced Wound Care Market Forecast: CAGR (%) by Sector, 2013-2018, 2018-2024,
and 2013-2024
Table 3.6 The Advanced Wound Care Market: Revenue ($bn) by Sector, 2012, 2018, 2024
Table 3.7 The Advanced Wound Care Market: Market Share (%) by Sector, 2012, 2018, 2024
Table 3.8 The Advanced Wound Care Market: Drivers and Restraints, 2014-2024
Table 4.1 Moist Wound Care Market: Revenues ($bn), Market Shares (%) and Growth (%) by
Sector, 2012 and 2013
Table 4.2 The Moist Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%) by Sector,
2012-2024
Table 4.3 Hydrocolloid Dressings Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-2024
Table 4.4 Foam Dressings Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-2024
Table 4.5 Alginate Dressings Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-2024
Table 4.6 Hydrogel Dressings Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-2024
Table 4.7 Selected Moist Wound Care Products, 2014
Table 4.8 Moist Wound Care Pipeline Products, 2014
www.visiongain.com

11. Contents
Table 4.9 SWOT Analysis of the Moist Wound Care Market, 2014-2024
Table 5.1 Wound Care Devices Market: Revenues ($bn), Market Shares (%) and Growth (%) by
Sector, 2012 and 2013
Table 5.2 The Wound Care Devices Market: Revenue Forecast ($bn, AGR%, CAGR%) by Sector,
2012-2024
Table 5.3 The Negative Pressure Wound Therapy (NPWT) Market: Revenue Forecast ($bn,
AGR%, CAGR%), 2012-2024
Table 5.4 The Negative Pressure Wound Therapy (NPWT) Market: Drivers and Restraints, 20142024
Table 5.5 Ultrasound Wound Therapy: Leading Products, 2014
Table 5.6 The Ultrasound Wound Therapy Market: Revenue Forecast ($bn, AGR%, CAGR%),
2012- 2024
Table 5.7 Electrical Stimulation Devices: Leading Products, 2014
Table 5.8 Wound Care Devices Pipeline Products, 2014
Table 5.9 SWOT Analysis of the Wound Care Devices Market, 2014-2024
Table 6.1 Wound Care Biologics Market: Revenues ($bn), Market Shares (%) and Growth (%) by
Sector, 2012 and 2013
Table 6.2 The Wound Care Biologics Market: Revenue Forecast ($m, AGR%, CAGR%) by Sector,
2012-2024
Table 6.3 Wound Care Biologics: Market Drivers and Restraints, 2014-2024
Table 6.4 Skin Replacement Therapies: Leading Products, 2014
Table 6.5 The Skin Replacement Therapies Market: Revenue Forecast ($m, AGR%, CAGR%),
2012- 2024
Table 6.6 Collagen Based Therapies: Leading Products, 2014
Table 6.7 The Collagen Based Therapies Market: Revenue Forecast ($m, AGR%, CAGR%), 20122024
Table 6.8 Cell Therapies: Leading Products, 2014
Table 6.9 The Cell Therapies Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 6.10 Other Wound Care Biologics Therapies, 2014
Table 6.11 Wound Care Biologics Pipeline Products, 2014
Table 6.12 SWOT Analysis of the Wound Care Devices Market, 2014-2024
www.visiongain.com

12. Contents
Table 7.1 The Advanced Wound Care Market: Revenues ($bn) and Growth (%) by Region, 2012
and 2013
Table 7.2 The Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%) by
Region, 2012-2024
Table 7.3 Advanced Wound Care Market Forecast: CAGR (%) by Region, 2013-2018, 20182024, and 2012-2024
Table 7.4 The Advanced Wound Care Market: Market Shares (%) by Region, 2012, 2018, 2024
Table 7.5 The US Advanced Wound Care Market Forecast: Market Size ($bn), Rank, Market
Share (%) and CAGR (%), 2012-2024
Table 7.6 US Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%), 20122024
Table 7.7 The EU5 Advanced Wound Care Market Forecast: Market Size ($bn), Market Share
(%) and CAGR (%), 2012-2024
Table 7.8 The EU5 Advanced Wound Care Market: Revenues ($bn) and Growth (%) by Region,
2012 and 2013
Table 7.9 The EU5 Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%) by
Country, 2012-2024
Table 7.10 The EU5 Advanced Wound Care Market: Market Shares (%) by Country, 2012, 2018,
2024
Table 7.11 The German Advanced Wound Care Market Forecast: Market Size ($bn), Rank,
Market Share (%) and CAGR (%), 2012-2024
Table 7.12 The German Advanced Wound Care Market: Revenue Forecast ($bn, AGR%,
CAGR%), 2012-2024
Table 7.13 The French Advanced Wound Care Market Forecast: Market Size ($bn), Rank, Market
Share (%) and CAGR (%), 2012-2024
Table 7.14 The French Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%),
2012-2024
Table 7.15 The UK Advanced Wound Care Market Forecast: Market Size ($bn), Rank, Market
Share (%) and CAGR (%), 2012-2024
Table 7.16 The UK Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%),
2012-2024
www.visiongain.com

13. Contents
Table 7.17 The Spanish Advanced Wound Care Market Forecast: Market Size ($bn), Rank,
Market Share (%) and CAGR (%), 2012-2024
Table 7.18 The Spanish Advanced Wound Care Market: Revenue Forecast ($bn, AGR%,
CAGR%), 2012-2024
Table 7.19 The Italian Advanced Wound Care Market Forecast: Market Size ($bn), Rank, Market
Share (%) and CAGR (%), 2012-2024
Table 7.20 The Italian Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%),
2012-2024
Table 7.21 The Japanese Advanced Wound Care Market Forecast: Market Size ($bn), Rank,
Market Share (%) and CAGR (%), 2012-2024
Table 7.22 The Japanese Advanced Wound Care Market: Revenue Forecast ($bn, AGR%,
CAGR%), 2012-2024
Table 7.23 The Chinese Advanced Wound Care Market Forecast: Market Size ($bn), Rank,
Market Share (%) and CAGR (%), 2012-2024
Table 7.24 The Chinese Advanced Wound Care Market: Revenue Forecast ($bn, AGR%,
CAGR%), 2012-2024
Table 7.25 The Indian Advanced Wound Care Market Forecast: Market Size ($bn), Rank, Market
Share (%) and CAGR (%), 2012-2024
Table 7.26 The Indian Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%),
2012-2024
Table 7.27 The Russian Advanced Wound Care Market Forecast: Market Size ($bn), Rank,
Market Share (%) and CAGR (%), 2012-2024
Table 7.28 The Russian Advanced Wound Care Market: Revenue Forecast ($bn, AGR%,
CAGR%), 2012-2024
Table 7.29 The Brazilian Advanced Wound Care Market Forecast: Market Size ($bn), Rank,
Market Share (%) and CAGR (%), 2012-2024
Table 7.30 The Brazilian Advanced Wound Care Market: Revenue Forecast ($bn, AGR%,
CAGR%), 2012-2024
Table 7.31 The South Korean Advanced Wound Care Market Forecast: Market Size ($bn), Rank,
Market Share (%) and CAGR (%), 2012-2024
Table 7.32 The South Korean Advanced Wound Care Market: Revenue Forecast ($bn, AGR%,
www.visiongain.com

14. Contents
CAGR%), 2012-2024
Table 8.1 KCI’s VAC Therapies at a Glance, 2014
Table 8.2 Smith & Nephew: Historical Revenue ($bn, AGR %), 2008-2012
Table 8.3 Smith & Nephew: Revenue by Segment ($bn), 2012
Table 8.4 Smith & Nephew Advanced Wound Management: Revenue ($bn) and Revenue Share
(%) by Segment, 2012
Table 8.5 Smith & Nephew Advanced Wound Management: Revenue ($bn) and Revenue Share
(%) by Region, 2012
Table 8.6 Molnlycke Advanced Wound Care Products and Description, 2014
Table 8.7 Molnlycke: Historical Revenue ($bn, AGR %), 2008-2012
Table 8.8 ConvaTec’s Wound Therapeutics Products and Description, 2014
Table 8.9 ConvaTec: Revenue ($m) and Revenue Share (%) by Segment, 2012
Table 8.10 ConvaTec: Historical Wound Therapeutics Revenue ($m, AGR %), 2009-2012
Table 8.11 3M: Revenue ($m) and Revenue Shares (%) by Franchise, 2012
Table 8.12 3M: Tegaderm Wound Care Products and Description, 2014
Table 8.13 3M: Historical Healthcare Revenue ($bn, AGR %), 2008-2012
Table 8.14 Coloplast: Revenue ($m) and Revenue Share (%) by Segment, 2013
Table 8.15 Coloplast: Revenue ($m) and Revenue Growth (%) by Region, 2012, 2013
Table 10.1 Projected Advanced Wound Care Market Size ($bn, CAGR%): 2012, 2017, 2020,
2024
Table 10.2 The Global Advanced Wound Care Market: Revenue ($bn) by Sector, 2012, 2017,
2020, 2024
Table 10.3 The Global Advanced Wound Care Market: Market Share (%) by Sector, 2012, 2017,
2020, 2024
List of Figures
Figure 2.1 Wound Healing Phases and Duration (Days)
Figure 2.2 Functions of Wound Dressing
Figure 3.1 The Medical Device Market: Revenue (£bn) by Sector, 2012
www.visiongain.com

15. Contents
Figure 3.2 The Medical Device Market: Market Shares (%) by Sector, 2012
Figure 3.3 Global Wound Care Market: Revenue ($bn) by Sector, 2012
Figure 3.4 Global Wound Care Market: Market Share (%) by Sector, 2012
Figure 3.5 The Advanced Wound Care Market: Revenues ($bn) by Sector, 2012 and 2013
Figure 3.6 The Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024
Figure 3.7 Advanced Wound Care Market Forecast: CAGR (%) by Sector, 2013-2018
Figure 3.8 Advanced Wound Care Market Forecast: CAGR (%) by Sector, 2018-2024
Figure 3.9 Advanced Wound Care Market Forecast: CAGR (%) by Sector, 2013--2024
Figure 3.10 The Advanced Wound Care Market: Revenue ($bn) by Sector, 2012, 2018, 2024
Figure 3.11 The Advanced Wound Care Market: Market Share (%) by Sector, 2012
Figure 3.12 The Advanced Wound Care Market: Market Share (%) by Sector, 2018
Figure 3.13 The Advanced Wound Care Market: Market Share (%) by Sector, 2024
Figure 4.1 Moist Wound Care Market: Revenue ($bn) by Sector, 2012
Figure 4.2 Moist Wound Care Market: Market Share (%) by Sector, 2012
Figure 4.3 The Moist Wound Care Market: Revenue Forecast ($bn), 2012-2024
Figure 4.4 Hydrocolloid Dressings Market: Revenue Forecast ($bn), 2012-2024
Figure 4.5 Foam Dressings Market: Revenue Forecast ($bn), 2012-2024
Figure 4.6 Alginate Dressings Market: Revenue Forecast ($bn), 2012-2024
Figure 4.7 Hydrogel Dressings Market: Revenue Forecast ($bn), 2012-2024
Figure 5.1 Wound Care Devices Market: Revenue ($bn) by Sector, 2012, 2013
Figure 5.2 Wound Care Devices Market: Market Share (%) by Sector, 2012
Figure 5.3 The Wound Care Devices Market: Revenue Forecast ($bn), 2013-2024
Figure 5.4 The Negative Pressure Wound Therapy (NPWT) Market: Revenue Forecast ($bn),
2012-2024
Figure 5.5 The Ultrasound Wound Therapy Market: Revenue Forecast ($bn), 2012-2024
Figure 6.1 Wound Care Biologics Market: Revenue ($bn) by Sector, 2012, 2013
Figure 6.2 Wound Care biologics Market: Market Share (%) by Sector, 2012
Figure 6.3 The Wound Care Biologics Market: Revenue Forecast ($m), 2012-2024
Figure 6.4 The Skin Replacement Therapies Market: Revenue Forecast ($m), 2012-2024
Figure 6.5 The Collagen Based Therapies Market: Revenue Forecast ($m), 2012-2024
Figure 6.6 The Cell Therapies Market: Revenue Forecast ($m), 2012-2024
www.visiongain.com

16. Contents
Figure 7.1 The Advanced Wound Care Market: Revenues ($bn) by Region, 2012
Figure 7.2 US, EU5, Japan, and China Advanced Wound Care Market: Revenue Forecast ($bn),
2012-2024
Figure 7.3 Russia, Brazil, and South Korea Advanced Wound Care Market: Revenue Forecast
($bn), 2012-2024
Figure 7.4 Advanced Wound Care Market Forecast: CAGR (%) by Region, 2013-2018
Figure 7.5 Advanced Wound Care Market Forecast: CAGR (%) by Region, 2018-2024
Figure 7.6 Advanced Wound Care Market Forecast: CAGR (%) by Region, 2013-2024
Figure 7.7 The Advanced Wound Care Market: Market Shares (%) by Region, 2012
Figure 7.8 The Advanced Wound Care Market: Market Shares (%) by Region, 2018
Figure 7.9 The Advanced Wound Care Market: Market Shares (%) by Region, 2024
Figure 7.10 US Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024
Figure 7.11 The EU5 Advanced Wound Care Market: Revenues ($bn) by Region, 2012
Figure 7.12 Germany, France, UK, Spain, and Italy Advanced Wound Care Market: Revenue
Forecast ($bn), 2012-2024
Figure 7.13 The EU5 Advanced Wound Care Market: Market Shares (%) by Country, 2012
Figure 7.14 The Advanced Wound Care Market: Market Shares (%) by Country, 2024
Figure 7.15 The German Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024
Figure 7.16 The French Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024
Figure 7.17 The UK Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024
Figure 7.18 The Spanish Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024
Figure 7.19 The Italian Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024
Figure 7.20 The Japanese Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024
Figure 7.21 The Chinese Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024
Figure 7.22 The Indian Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024
Figure 7.23 The Russian Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024
Figure 7.24 The Brazilian Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024
Figure 7.25 The South Korean Advanced Wound Care Market: Revenue Forecast ($bn), 20122024
Figure 8.1 Kinetic Concept Inc: Strengths and Threats, 2014-2024
Figure 8.2 Smith & Nephew: Historical Revenue ($bn), 2008-2012
www.visiongain.com

17. Contents
Figure 8.3 Smith & Nephew: Revenue by Segment ($bn), 2012
Figure 8.4 Smith & Nephew: Revenue by Segment (%), 2012
Figure 8.5 Smith & Nephew Advanced Wound Management: Revenue ($bn) by Franchise, 2012
Figure 8.6 Smith & Nephew Advanced Wound Management: Revenue Share (%) by Franchise,
2012
Figure 8.7 Smith & Nephew Advanced Wound Management: Revenue ($bn) by Region, 2012
Figure 8.8 Smith & Nephew Advanced Wound Management: Revenue Share (%) by Region,
2012
Figure 8.9 Molnlycke: Strengths and Threats, 2014-2024
Figure 8.10 Molnlycke: Historical Revenue ($bn), 2008-2012
Figure 8.11 ConvaTec: Revenue ($m) by Segment,, 2012
Figure 8.12 ConvaTec: Revenue Share (%) by Segment,, 2012
Figure 8.13 ConvaTec: Historical Wound Therapeutics Revenue ($m), 2009-2012
Figure 8.14 3M: Revenue Shares (%) by Franchise, 2012
Figure 8.15 3M: Historical Healthcare Revenue ($bn), 2008-2012
Figure 8.16 Coloplast: Revenue ($m) by Segment, 2013
Figure 8.17 Coloplast: Revenue Share (%) by Segment, 2013
Figure 8.18 Coloplast: Revenue ($m) by Region, 2012, 2013
Figure 8.19 Coloplast: Revenue Share (%) by Region, 2013
Figure 10.1 Projected Advanced Wound Care Market Size ($bn): 2012, 2017, 2020, 2024
Figure 10.2 The Global Advanced Wound Care Market: Revenue ($bn) by Sector, 2012, 2017,
2020, 2024
Figure 10.3 Global Over-60 Population: Historical Proportions and Forecast (%), 1950, 2009,
2050
Figure 10.4 The Global Advanced Wound Care Market: Market Share (%) by Sector, 2012, 2017,
2020, 2024
www.visiongain.com

18. Contents
Companies Mentioned in this Report
3M
Advanced BioHealing (Shire)
Advanced Tissue Sciences
Anika Therapeutics
Avista Capital Partners
Avita Medical
Biolight AB
BlueSky Medical (S&N)
Boehringer Ingelheim
Brennen Medical
Bristol-Myers Squibb
BSN Medical Gmbh
Celleration
Coloplast
ConvaTec
Covalon Technologies
Covidien
Derma Sciences
Devon Medical Products
Dow-Hickman
Dr Suwelack Skin & Health Care
Garnet Biotherapeutics
Genzyme Biosurgery
Gerromed GmbH
Getinge
Forticell Bioscience (formerly Ortec International)
Hartmann Group
Healo Medical
www.visiongain.com

19. Contents
Healthpoint Biotherapeutics
Hollister Wound Care
Human Biosciences
Ingenious Technologies Corporation
Innocoll
Innovative Therapies
Integra Life Science Corp
Investor AB
IYIA Technologies
Johnson & Johnson
Kaken Pharmaceuticals
Kalypto Medical
Kinetic Concepts
Laboratoires URGO
Lescarden
Lifecell
Lightwave Technologies
MacroCure
Marine Polymer Technologies Inc
Medela
Medestea Internazionale
Medline Industries
MiMedX
MiMedX
Misonix
Molnlycke
Mo-Sci Corporation
Nanotherapeutics
Nordic Capital Partners
Organogenesis
Osiris Therapeutics
www.visiongain.com

20. Contents
Politec Saude
Polyheal
Promethean LifeSciences
Prospera
Phytoceuticals
RedDress
Sangui BioTech International
Sanuwave Health
Shire Regenerative Medicine
Smith & Nephew
Soring
Synapse Microcurrent
Systagenix (now part of KCI)
Talley Group
Vario
Vomaris Innovations
Wake Forest University
Wound Management Technologies
Wright Medical
www.visiongain.com

21. Contents
Organisations Mentioned in this Report
Armed Forces Institute of Regenerative Medicine (AFIRM)
Center for Disease Control
Centers for Medicare and Medicaid Services (CMS)
Central Drug Standard Control Organisation (CDSCO) [India]
Centre for Devices and Radiological Health (CDRH)
Cornell University
European Databank on Medical Devices (EUDAMED)
Food and Drug Administration (FDA)
Fraunhofer Institute
Health Insurance Bureau [Japan]
Institute of Photomedicine, Harvard University
International Diabetic Federation (IDF)
International Medical Device Regulators Forum (IMDRF) (formerly GHTF)
Italian National Health Service
Masachussetts General Hospital (MGH)
McGowan Institute for Regenerative Medicine, University of Pittsburgh
Ministry of Health & Family Welfare [India]
Ministry of Health, Labour and Welfare (MHLW)
Ministry of Health, Labour, and Welfare (MHLW) [Japan]
Missouri University of Science and Technology
Moody’s Investor service
Nara University, Japan
National Competent Authorities (NCAs)
National Health Service (NHS)
North Florida/ South Georgia Veterans Health System
Pharmaceuticals and Medical Devices Agency (PMDA) [Japan]
Roszdravnadzor [Russia]
Standard and Poors Rating Services
www.visiongain.com

22. Contents
The World Bank
University of California, Berkeley
United Nations (UN)
University Hospital Bern
Wellman Centre for Photomedicine, Harvard University
www.visiongain.com

23. Advanced Wound Care: Market Forecast 2014-2024
& Future Prospects for Leading Companies
Table 4.3 Hydrocolloid Dressings Market: Revenue Forecast ($bn, AGR%, CAGR%),
2012-2024
2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Hydrocolloid
Dressing ($bn)
1.2
AGR (%)
CAGR (%) 2013-18
1.3
1.3
1.3
1.4
1.4
1.5
1.6
1.6
1.6
1.6
1.7
1.7
2
3
3
3
4
4
4
1
2
2
1
1
3.4
2018-24
CAGR (%) 2013-24
1.8
2.5
Source: Visiongain 2014
Visiongain forecasts the revenue from hydrocolloid dressings to reach $1.5bn in 2018 (Figure 4.4),
growing at a CAGR of 3.4% from 2013. The hydrocolloid dressing market will be driven by
increased prevalence of chronic and acute wounds. This market is dominated by multinational
companies such as 3M, ConvaTec, Smith &Nephew, and Coloplast who have been in the market
for a long while. Controversy regarding the use of hydrocolloid dressings in the treatment of
diabetic ulcers may restrain growth in the market during the forecast period. Visiongain predicts
slow growth in the hydrocolloid dressing market from 2014 to 2024 with the market growing to
$1.7bn in 2024, at a CAGR of 1.8% from 2018 to 2024.
4.2.2 Foam Dressings: Analysis and Forecast, 2014-2024
Foam dressings accounted for 26.5% of the moist wound care market with $1.0bn in global sales.
Many foam dressings in the market have been combined with anti-bacterials such as silver to
reduce infection and to heal wounds faster. As more innovative combinations reach the market, the
benefits of foam dressings will be seen. ALLEVYN (Smith & Nephew), Lyofoam (Molnlycke) and
3M Tegaderm Foam (3M) are some of the leading foam dressings in the market. The versatility
and affordability of foam dressings makes them an attractive choice among moist wound care
products. Emerging economies will drive growth in the moist wound care market, and visiongain
predicts that foam dressings will benefit the most. The foam dressing market will increase to
$1.4bn in 2018, with a CAGR of 6.0% between 2013 and 2018. The market will then increase to
$1.7bn in 2024, growing at a CAGR of 3.5% between 2018 and 2024 (Table 4.4 and Figure 4.5).
www.visiongain.com
Page 68

24. Advanced Wound Care: Market Forecast 2014-2024
& Future Prospects for Leading Companies
Table 7.32 The South Korean Advanced Wound Care Market: Revenue Forecast ($bn,
AGR%, CAGR%), 2012-2024
2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
South Korean
Market ($bn)
AGR (%)
0.1
0.1
0.1
0.1
0.2
0.2
0.2
0.2
0.3
0.3
0.3
0.3
0.4
12
12
12
14
14
15
13
13
11
10
9
8
13.4
CAGR (%) 2013-18
2018-24
10.4
11.8
CAGR (%) 2013-24
Source: Visiongain 2014
Figure 7.25 The South Korean Advanced Wound Care Market: Revenue Forecast ($bn),
2012-2024
0.4
0.4
0.3
0.3
0.3
Revenue ($bn)
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.0
2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Year
Source: Visiongain 2014
www.visiongain.com
Page 153

25. Advanced Wound Care: Market Forecast 2014-2024
& Future Prospects for Leading Companies
Figure 8.1 Kinetic Concept Inc: Strengths and Threats, 2014-2024
Threats
Strengths
World leader in NPWT market offering a
KCI will likely face strong competition to
wide range of products based on its
maintain its market position in the NPWT
proprietary V.A.C therapy technology. KCI is
market.
the trusted brand around the world for
NPWT products
It will have to compete with other established
providers of NPWT products as well as
KCI is strong in the biologics segment since
newer companies introducing several NPWT
the acquisition of LifeCell Technologies in
devices on the market.
2008. KCI is also constantly growing through
expansion into under penetrated markets.
The acquisition of Systagenix will help
consolidate its possible as market leader in
the AWC market
Source: Visiongain 2014
Systagenix is based in the UK, and in collaboration with Alere developed WOUNDCHEK Protease
status, the world’s first point of care diagnostic test for chronic wounds. The product was launched
in January 2012 across Europe, South Africa and the Middle East. Although it has been widely
understood that Elevated Protease Activity (EPA) is the key marker in wound healing, it used to be
undetected in the past. The Wound Check protease for EPA measurement provides results in 15
minutes enabling the clinician to decide the best treatment for each patient. The product has not
yet been approved by the US FDA.
KCI decided to expand its operations to Brazil in 2012, following the previous year’s launch of its
NPWT systems in the Japanese, Chinese and Indian markets. This will help the company to boost
its revenue during the forecast period. The merger between KCI and Systagenix will help to
diversify the group’s product portfolio, which will act as a catalyst to stimulate revenue growth for
the group (Figure 8.1).
www.visiongain.com
Page 158